SUMMARY
UMAN atrial natriuretic peptide (hANP) has been shown to have many biological effects, such as natriuretic, diuretic and smooth muscle relaxant effects.1)-6) The plasma hANP level is high in patients with congenital heart diseases with volume overloading,7),8) congestive heart failure (CHF)9)-12) and renal failure.13) Moreover, plasma hANP levels increase in response to acute volume expansion14) and atrial pacing.15),16) The clinical observations that supraventricular tachycardia and acute water loading often induce polyuria seem to be related to an increase in hANP secretion.17), 18) In the present study we examined the capacity of VSD patients with and without CHF to secrete hANP in response to atrial pacing, and its subsequent diuretic and natriuretic effects in these patients.
SUBJECTS AND METHODS
The study was carried out in 9 patients with a history of Kawasaki disease (as controls), and 11 VSD patients. Data on the VSD patients are given in Table I . They ranged from 6 to 40 months old and were subdivided into those with and without CHF. CHF was determined on the basis of cardiothoracic ratio, Qp/Qs ratio and clinically. All these patients were admitted to Tokushima University Hospital for cardiac catheterization.
Written consent was obtained from the parents for participation of these patients in this study. The patients were kept in bed and received a maintenance infusion at least 12 hours before catheterization.
After premedication and local anesthesia, the pacing catheter was inserted into the right atrium from a femoral vein. Right atrial pacing was performed at a rate of 200 beats/min for 10min.
The systemic blood pressure and heart rate were monitored using a standard cuff and semiautomatic device. Patients in whom the blood pres- sure decreased more than 10mmHg and in whom arrhythmia appeared during atrial pacing were excluded from this study, because a large hemodynamic change may affect the renal hemodynamics. Urine was collected through an indwelling urethral catheter, and the urine samples were obtained every 10min. The samples collected for 20 min before pacing, for 10min during pacing and for 20min after pacing were examined. The urine volume was precisely measured for determination of the urine flow rate (ml/kg/min) in each collection period. The urinary sodium, chloride and potassium concentrations (mEq/l) were determined by flame photometry, and the excretions of these electrolytes were calculated as the products of the urine volume and concentration of the electrolytes in each collection period.
Blood samples were withdrawn from a femoral vein into cooled plastic syringes containing EDTA (2.5mg/ml) and aprotinin (500 kallikrein inactivator units/ml) before pacing, at the end of pacing and 10min after pacing. Plasma was separated by centrifugation and applied to Sep-Pak C18 cartridges for extraction of hANP as reported previously.7),8) The hANP level was measured by radioimmunoassay with antibody. excretion were less than those in controls, although the plasma hANP levels were higher. Cody et al12) also observed little diuresis or natriuresis in response to hANP infusion in adult patients with CHF. This is consistent with our results in patients with CHF. Several reasons for this refractoriness to hANP in CHF have been considered. One is a decrease in the receptor number in the kidney in patients with chronically elevated plasma hANP levels (i.e., down regulation of receptors).20) Hirata et al20) showed that pretreatment of rat aortic vascular smooth muscle cells with unlabeled hANP resulted in a substantial reduction of their total hANP receptor number without changing the affinity of these receptors.
Other possible reasons for the lack of natriuresis and diuresis are abnormalities in renal blood flow, renal perfusion pressure and the body fluid volume status.
Judging from their capacity to secrete hANP and the response of their kidneys to hANP, the VSD patients with volume overloading without CHF were intermediate between the controls and VSD patients with CHF. Thus VSD patients without CHF may be in a condition of latent heart failure. Decreased responsiveness to endogenous hANP may play a role in the pathogenesis of sodium and water retention in CHF.
